New Testing Device Helps Identify Risk for Preterm Birth
Researchers have developed a testing device that may help advance diagnosis and treatment of preterm birth.
Category: Womens Health
Womens Health
Latest
Womens Health
Latest
Inito Launches At-Home Fertility Test
The Inito device, paired with an app, is an at-home test measuring hormone values for estrogen, luteinizing hormone, and progesterone.
Womens Health
Latest
FDA Clears Ava Fertility Tracker Wearable
This is the first and only FDA-cleared fertility tracking wearable clinically proven as effective as LH tests in predicting ovulation—and with more fertile days detected.
Study: Enhanced Common Blood Test Could Predict Adverse Outcomes in Pregnancy
A blood test commonly used to detect fetal genetic abnormalities can be modified to help predict complications associated with pregnancy before any symptoms develop, according to UCLA researchers and colleagues.
Read More
Advancing the Diagnosis of Vaginitis
Two FDA-approved molecular testing platforms are leading to better targeted treatments for this common infection.
Read More
Viewpoint | ACS Guidelines for Cervical Cancer Screening: A Step Backward?
A board-certified obstetrician and gynecologist expresses his concerns about the new ACS cervical cancer screening guidelines.
Read More
Myriad’s Amplify Technology Improves Prequel NIPS Test
The Amplify process increases the fetal fraction of a NIPS sample by preferentially sequencing the fetal cell-free DNA fragments that circulate in a mother’s blood.
Read More
BD Gets FDA Approval for Extended HPV Testing
BD received a pre-market approval supplement from the FDA for an expanded version of its BD Onclarity HPV Assay.
Read More
Novel Biomarker Discovery Could Lead to Early Diagnosis of Preeclampsia
The discovery of two novel biomarkers—FKBPL and CD44—has the potential to change the way preeclampsia is managed.
Read MorePerkin Elmer to Distribute Preeclampsia Detection Device
The preeclampsia detection kit is a highly accurate, urine-based, noninvasive point-of-care test, meaning no specialized instrumentation or equipment is needed.
Read MoreBillionToOne Has Closed Its Follow-On Series A+ Funding Round of $15 Million
The new funding will be used to support commercial expansion of the company’s Unity prenatal screening test to all US states as well as research and development for future diagnostics.
Read More
FDA Clears Hologic Assays for Diagnosis of Vaginitis
Improved accuracy in identifying bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis will enable better targeted treatment for women.
Read MoreFDA Clears High-Sensitivity Troponin-I Blood Test from Abbott
The newly cleared diagnostic could help identify heart attacks several hours sooner than standard troponin tests—and help improve diagnoses in women.
Read More
Molecular Assays Focus on Diagnostic Testing for Vaginitis
Improved accuracy in detecting bacterial vaginosis, Candida vaginitis, and Trichomonas vaginalis will enable more targeted treatment for women.
Read More
FDA Clears First Diagnostics for Extragenital Chlamydia and Gonorrhea
The Aptima Combo 2 and Xpert CT/NG are the first assays cleared to perform extragenital diagnostic testing for chlamydia and gonorrhea via specimens from the throat and rectum.
Read More
LGC Maine Standards Releases Validate LP Kit to Enhance Linearity and Calibration Verification
The Validate LP kit for Advia and Atellica analyzers from Siemens Healthineers addresses a growing demand from laboratories in need of a product to document HDL and LDL linearity and calibration verification.
Read More
Thermo Fisher Scientific and NX Prenatal Collaborate to Develop Fetal Health Assays
Thermo Fisher and NX Prenatal will develop clinical mass spectrometry-based workflows for monitoring maternal and fetal health during pregnancy, and evaluating the risk of complications.
Read More
April 2019 Product Spotlight: Immunoassay Analyzers
April 2019’s product spotlight includes immunoassay kits and analyzers from companies such as Fujirebio, Ansh Labs, Tosoh Bioscience, and more.
Read More